Log In
person
Eagle Pharmaceuticals Inc
EGRX
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2022
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Injectable Pharmaceuticals |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
214.54M | 67.76% |
| Injectable Pharmaceuticals |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
98.27M | 31.04% |
| Injectable Pharmaceuticals |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
3.81M | 1.20% |
| keyboard_arrow_down |
Injectable Pharmaceuticals
Branded Pharmaceuticals (outsourced)
|
214.54M | 67.76% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Injectable Pharmaceuticals
Pharmaceutical Patent Licensing
|
98.27M | 31.04% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Injectable Pharmaceuticals
Pre-Revenue Pharmaceuticals
|
3.81M | 1.20% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||